IMPROVE2CARE
ActiveSummary
IMPROVE2CARE has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €66,099 and a net result of €107,296. Equity is shrinking by ~4.7% per year across the filed fiscal years. Its solvency ranks better than 19% of 19921 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability100▲+63
Solvency53▼-15
Growth58▲+26
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €5,000 at 30 days acceptable
Liquidity tight (current ratio 1.23 against 1.56 in 2023; short-term debt: 65.1% and cash: 39.5% of total assets), and 72.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 19921 sector peers (2024).
NBB · sector comparisonPosition among 19921 sector peers
Solvency
better than 19%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 15-07-2025, 16 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
16 d early
2023
on the day
2022
29 d late
2021
31 d late
2020
41 d late
2019
128 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 7 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Equity
€66,099▲ 12.4%
2023 · €58,804
Total assets
€237,360▲ 74.0%
2023 · €136,451
Net result
€107,296
2023 · -€4,485
Working capital
€35,876▲ 25.6%
2023 · €28,566
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€4,062▼ 98.1%€39,343▲ 869%€41,772▲ 6.2%€324▼ 99.2%€152,765▲ 47,105%
Net result-€5,007below the sector's middle half€22,432within the sector's middle half€27,009within the sector's middle half▲ 20.4%-€4,485below the sector's middle half€107,296within the sector's middle half
Equity€66,963within the sector's middle half▼ 7.0%€89,395within the sector's middle half▲ 33.5%€79,588within the sector's middle half▼ 11.0%€58,804within the sector's middle half▼ 26.1%€66,099within the sector's middle half▲ 12.4%
Total assets€217,002within the sector's middle half▼ 35.5%€159,080within the sector's middle half▼ 26.7%€196,791within the sector's middle half▲ 23.7%€136,451within the sector's middle half▼ 30.7%€237,360within the sector's middle half▲ 74.0%
Debt€150,040▼ 43.3%€69,685▼ 53.6%€117,203▲ 68.2%€77,648▼ 33.7%€171,260▲ 121%
Working capital€34,838within the sector's middle half▼ 25.9%€65,483within the sector's middle half▲ 88.0%€52,357within the sector's middle half▼ 20.0%€28,566within the sector's middle half▼ 45.4%€35,876within the sector's middle half▲ 25.6%
Solvency30.9%below the sector's middle half▲ 9.5pp56.2%within the sector's middle half▲ 25.3pp40.4%within the sector's middle half▼ 15.8pp43.1%within the sector's middle half▲ 2.7pp27.8%below the sector's middle half▼ 15.2pp
Current ratio1.26below the sector's middle half▲ 0.072.10within the sector's middle half▲ 0.851.70within the sector's middle half▼ 0.411.56within the sector's middle half▼ 0.141.23below the sector's middle half▼ 0.32
Return on assets (ROA)-2.3%below the sector's middle half▼ 46.9pp14.1%within the sector's middle half▲ 16.4pp13.7%within the sector's middle half▼ 0.4pp-3.3%below the sector's middle half▼ 17.0pp45.2%above the sector's middle half▲ 48.5pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 47,105% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €237,360
Fixed assets
€46,845 ▼ 17.2%
Current assets
€190,515 ▲ 138%
Equity and liabilities €237,360
Equity
€66,099 ▲ 12.4%
Debt
€171,260 ▲ 121%
Debt's share of the balance-sheet total rises from 56.9% to 72.2%. Equity and debt are higher.
Key figures and ratios
EBITDA
€165,574▲
2023 · €14,352
Cash flow
€120,104▲
2023 · €9,544
Debt to equity
2.59▲
2023 · 1.32
ROE
162.3%▲
2023 · -7.6%
Interest coverage
38.49▲
2023 · 2.68
Debt ≤ 1 year
€154,639▲
2023 · €51,338
Debt > 1 year
€16,621▼
2023 · €26,310
Income taxes
€41,519▲
2023 · -€544
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 5,053 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 96% are still going.
- Micro
- 10 to 20 years old
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
1.6%
went bankrupt
2.4%
stopped otherwise
96%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 5,053 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | €0 | - | - | - | - |
| Remuneration, social security and pensions62 | - | - | €0 | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €12,949 | €15,754 | €12,067 | €14,028 | €12,808 | ▼ 8.7% |
| Other operating charges640/8 | - | €955 | €2,496 | €990 | €2,152 | ▲ 117% |
| Gross operating margin9900 | €18,842 | €56,051 | €56,335 | €15,342 | €167,726 | ▲ 993% |
| Operating profit (loss)9901 | €4,062 | €39,343 | €41,772 | €324 | €152,765 | ▲ 47,105% |
| Financial income75/76B | - | €0 | €9 | €12 | €351 | ▲ 2,895% |
| Recurring financial income75 | €150 | €0 | €9 | €12 | €351 | ▲ 2,895% |
| Financial charges65/66B | - | €2,910 | €4,281 | €5,364 | €4,301 | ▼ 19.8% |
| Recurring financial charges65 | €4,146 | €2,910 | €4,281 | €5,364 | €4,301 | ▼ 19.8% |
| Profit (loss) for the period before taxes9903 | €66 | €36,432 | €37,500 | -€5,028 | €148,815 | ▲ 3,059% |
| Income taxes67/77 | €5,073 | €14,000 | €10,491 | -€544 | €41,519 | ▲ 7,734% |
| Profit (loss) for the period9904 | -€5,007 | €22,432 | €27,009 | -€4,485 | €107,296 | ▲ 2,493% |
| Profit (loss) for the period to be appropriated9905 | -€5,007 | €22,432 | €27,009 | -€4,485 | €107,296 | ▲ 2,493% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €217,002 | €159,080 | €196,791 | €136,451 | €237,360 | ▲ 74.0% |
| Fixed assets21/28 | €46,614 | €34,184 | €69,308 | €56,548 | €46,845 | ▼ 17.2% |
| Tangible fixed assets22/27 | €46,614 | €34,184 | €69,308 | €56,548 | €46,845 | ▼ 17.2% |
| Land and buildings22 | - | - | €38,552 | €34,396 | €30,240 | ▼ 12.1% |
| Plant, machinery and equipment23 | - | €600 | €163 | €1,007 | €3,340 | ▲ 232% |
| Furniture and vehicles24 | - | €12,247 | €11,394 | €7,404 | €4,984 | ▼ 32.7% |
| Other tangible fixed assets26 | - | €21,338 | €19,199 | €13,740 | €8,281 | ▼ 39.7% |
| Current assets29/58 | €170,388 | €124,896 | €127,482 | €79,903 | €190,515 | ▲ 138% |
| Amounts receivable within one year40/41 | €23,447 | €3,243 | €18,376 | €33,198 | €49,753 | ▲ 49.9% |
| Trade receivables40 | - | €3,243 | €17,813 | €9,680 | €26,572 | ▲ 175% |
| Other amounts receivable41 | - | - | €563 | €23,518 | €23,181 | ▼ 1.4% |
| Cash at bank and in hand54/58 | €143,593 | €119,613 | €94,495 | €28,483 | €93,690 | ▲ 229% |
| Deferred charges and accrued income490/1 | - | €2,040 | €14,612 | €18,222 | €47,072 | ▲ 158% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €217,002 | €159,080 | €196,791 | €136,451 | €237,360 | ▲ 74.0% |
| Equity10/15 | €66,963 | €89,395 | €79,588 | €58,804 | €66,099 | ▲ 12.4% |
| Contributions10/11 | - | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €53,116 | €53,116 | €60,988 | €40,204 | €47,499 | ▲ 18.1% |
| Non-distributable reserves130/1 | - | €1,860 | €0 | - | - | - |
| Reserves not available under the articles1311 | - | €1,860 | €0 | - | - | - |
| Distributable reserves133 | - | €51,256 | €60,988 | €40,204 | €47,499 | ▲ 18.1% |
| Profit (loss) carried forward14 | -€4,754 | €17,679 | €0 | €0 | €0 | - |
| Amounts payable17/49 | €150,040 | €69,685 | €117,203 | €77,648 | €171,260 | ▲ 121% |
| Amounts payable after more than one year17 | €14,490 | €10,272 | €42,078 | €26,310 | €16,621 | ▼ 36.8% |
| Financial debts170/4 | - | €10,272 | €42,078 | €26,310 | €16,621 | ▼ 36.8% |
| Amounts payable within one year42/48 | €135,550 | €59,413 | €75,125 | €51,338 | €154,639 | ▲ 201% |
| Current portion of amounts payable after more than one year42 | - | €4,217 | €15,297 | €29,319 | €25,006 | ▼ 14.7% |
| Trade debts44 | €2,454 | €8,663 | €767 | €3,438 | €2,014 | ▼ 41.4% |
| Suppliers440/4 | - | €8,663 | €767 | €3,438 | €2,014 | ▼ 41.4% |
| Taxes, remuneration and social security45 | - | €9,000 | €29,983 | €10,934 | €42,619 | ▲ 290% |
| Taxes450/3 | - | €9,000 | €29,983 | €10,934 | €42,619 | ▲ 290% |
| Remuneration and social security454/9 | - | €0 | - | - | - | - |
| Other amounts payable47/48 | - | €37,533 | €29,078 | €7,646 | €85,000 | ▲ 1,012% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€5,007 | €22,432 | €27,009 | -€4,485 | €107,296 | ▲ 2,493% |
| + Depreciation and write-downs630 | €12,949 | €15,754 | €12,067 | €14,028 | €12,808 | ▼ 8.7% |
| Operating cash flow (approximation) | €7,942 | €38,186 | €39,077 | €9,544 | €120,104 | ▲ 1,158% |
| Investment in fixed assets (approximation) | - | -€3,324 | -€47,191 | -€1,268 | -€3,105 | ▼ 145% |
| Change in cash | - | -€23,980 | -€25,118 | -€66,012 | €65,207 | ▲ 199% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
15-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Back to profitnet €107,296
Net result €107,296 after one loss-making year.
31-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 29 days late
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
08-07
State Gazette act
Board meeting · Director resignation
Director appointment · Permanent representative
2021
31-12
Financial
Back to profitnet €22,432
Net result €22,432 after one loss-making year.
10-09
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 41 days late
06-07
State Gazette act
Board meeting · Director appointment
Permanent representative
2020
31-12
Financial
Weakest financial yearnet -€5,007
Net result drops to -€5,007, the lowest in the series; recovery starts the following year.
25-03
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Highest result since 2018net €150,020 ▲888%
Operating result €212,778, net result €150,020, both a record.
Show earlier events
17-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
09-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 31 days late
2016
19-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 19 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Keerbergen · 1 establishment unit since 2014
Ground area
5,270 m²
Building footprint
368 m²
Volume, LiDAR
1,249 m³
Parcel 24472E0138/00M000, Flanders · tallest building 5.8 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
B.V.B.A. Dr. Inge Wouters, urologie
since 20142.227.536.605
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24472E0138/00M000 | Flanders | 5,270 m² | 1 · 368 m² | 5.8 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2025 · 4 entries · 5,814 EUR awarded · 5,814 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 240 EUR | 240 EUR |
| 2024 | 1 | 1,154 EUR | 1,154 EUR |
| 2023 | 1 | 1,766 EUR | 1,766 EUR |
| 2022 | 1 | 2,654 EUR | 2,654 EUR |
Similar companies · same sector, comparable size
Dr Ysabel Struye
BE 0671.800.719
Rixensart · Eq €66,026
SRKmed
BE 1002.464.910
Brussel · Eq €66,016
DOCTEUR GILLES MARECHAL
BE 0877.779.625
Liège · Eq €66,000
DOCTEUR LONGERSTAY MEDICAL
BE 0879.251.649
Verlaine · Eq €66,000
DR. JOACHIM VAN KEIRSBILCK
BE 0506.816.189
Brugge · Eq €66,200
Of 16,627 companies in sector 86220 we hold annual accounts for 7,988. 5,610 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded18-02-2014
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
82990Other business support services
85599Other education
Contact
E-mail
ingewouters@me.com
Phone
0475948847
E-invoicing
Reachable via Peppol
Peppol ID
0208:0546651517
Also
9925:BE0546651517
Registered
24-11-2023
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.